wigglethemouse
Senior Member
- Messages
- 776
I think the antibody titer assumptions came from this small earlier 2006 paper by Montoya but I think it didn't hold up in larger numbers or in the clinic.This is a study done by Jose Montoya. Who is a big advocate of viral reactivations being behind ME/CFS.
Note that he uses elevated IgG antibody titers against HHV-6 and EBV as criteria for the study and treatment. However, in the next to the last paragraph, he says
"Viral IgG antibody titers did not differ between arms" after treatment.
To me this says the valganciclovir did not treat the viruses/high antibody titers. So it must have worked in some other way. It doesn't make sense to me that he would use high antibody titers for establishing the cause of these patients ME/CFS and criteria for treatment.
Use of Valganciclovir in Patients With Elevated Antibody Titers Against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) Who Were Experiencing Central Nervous System Dysfunction Including Long-Standing Fatigue
Pubmed : https://pubmed.ncbi.nlm.nih.gov/17276366/
Sci-hub : https://sci-hub.se/https://www.sciencedirect.com/science/article/abs/pii/S1386653206700099?via=ihub